CSI Market
Sign In | Register

Neuphoria Therapeutics Inc (NEUP) Annual Balance Sheets

Annual · GAAP · USD millions
Access NEUP quarterly Balance Sheets →
This balance sheet overview for Neuphoria Therapeutics Inc spans from Jun 30 2022 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Jun 30 2025) (Jun 30 2024) (Jun 30 2023) (Jun 30 2022)
Assets
Cash & cash equivalent19.87
Cash, Cash Equivalents Other0.00
Restricted Cash0.00
Cash & Short-term Investments19.00
Accounts receivable0.81
Trade & Other Current Receivables (IFRS combined total)-
Notes Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.39
Total Current Assets21.07
Equipment/Property/Plant Net0.00
Goodwill net3.50
Intangible Assets4.14
Long-term investments0.00
Tax Assets, Noncurrent26.18
Other Assets, Noncurrent0.00
Trade And Other Current Receivables-
Research And Development Incentives Receivable-
Other Current Nonfinancial Assets-
Rightofuse Assets-
Intangible Assets Other Than Goodwill-
Other Noncurrent Nonfinancial Assets-
Noncurrent Assets-
Total Assets28.71
Liabilities
Accounts Payable, Current AC0.39
Accrued Liabilities And Other Liabilities0.37
Other Liabilities, Current0.00
Deferred Liability and Revenue0.00
Total Current Liabilities0.76
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.06
Accrued Income Taxes, Noncurrent1.14
Other liabilities, Noncurrent2.16
Noncurrent Lease Liabilities-
Total Liabilities4.11
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock218.46
Retained Earnings / Accumulated Deficit-191.80
Accumulated Other Comprehensive Income-2.06
Defined Benefit Plan and Other1.97
Other Equity-2.06
Common Stockholder's Equity24.60
Total Stockholder's Equity24.60
Liabilities & Stockholder's Equity28.71
4 historic quarters locked

Sign in to unlock the full Neuphoria Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Neuphoria Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20260630)
  • Filed with the SEC: September 18, 2026
  • Source: neup-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-395536

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License